REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mamygeny Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Ambulatory Health Care Services
Full name: Mamygeny Sp. z o.o. Profile Updated: January 15, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Mamygeny Sp. z o.o. is an enterprise in Poland, with the main office in Leszno. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was established on August 21, 2023. Over the same period, its total assets grew by 1481.34%.

Headquarters
Ul. Geodetow 1
Leszno; Wielkopolskie; Postal Code: 64-100

Contact Details: Purchase the Mamygeny Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Mamygeny Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Mamygeny Sp. z o.o. report to view the information.
Incorporation Date:
August 21, 2023
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
34%
Purchase this report to view the information.
33%
Purchase this report to view the information.
33%
Company Performance
Financial values in the chart are available after Mamygeny Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit
N/A
Net Profit/Loss for the Period
N/A
Total Assets
1481.34%▲
Total Equity
N/A
Return on Equity (ROE)
0.89%▲

Similar companies

Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji
 
Astellas Pharma Sp. z o.o.
Instytut Hematologii I Transfuzjologii
 
Angelini Pharma Polska Sp. z o.o.
Siec Badawcza Lukasiewicz-Instytut Lotnictwa
 
Przedsiebiorstwo Farmaceutyczne Lek-Am Sp. z o.o.
Centrum Badawczo Rozwojowe Inova Sp. z o.o.
 
Innosil Sp. z o.o.
Ai Hexeract Sp. z o.o.
 
Oncotherics Poland S.A.
7Fconnect Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo